Lv52
1140 积分 2023-05-20 加入
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
11天前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
13天前
已完结
The story of amylin: from physiology to therapy
1个月前
已完结
Dynamics of fat cell turnover in humans
1个月前
已完结
Dynamics of fat cell turnover in humans
1个月前
已完结
Fat Tissue Growth and Development in Humans
1个月前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
2个月前
已完结
A combinatorial siRNA and mRNA approach for obesity treatment using targeting lipid nanoparticles
2个月前
已完结
Pharmacokinetic and Pharmacodynamic Effects of Multiple-dose Administration of Omarigliptin, a Once-weekly Dipeptidyl Peptidase-4 Inhibitor, in Obese Participants With and Without Type 2 Diabetes Mellitus
2个月前
已完结
Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target
2个月前
已完结
皖公网安备34019202002308